Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christopher Leptak
Observed names:
C Leptak,
Chris Leptak
Institutions:
Cincinnati Children's Hospital Medical Center,
University of Cincinnati
Observed institutions:
Cincinnati Children's Hospital Medical Center,
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
University of Cincinnati
ORCID:
0000-0002-8457-740X
Observed ORCID:
0000-0002-8457-740X
OpenAlex ID:
A5064087482
Alcohol‐Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study†
2019
·
Gyongyi Szabo
, Patrick S. Kamath
, et al.
·
Hepatology
·
120
Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update
2009
·
Ann Corken Mackey
, Lanh Green
, et al.
·
Journal of Pediatric Gastroenterology and Nutrition
·
117
What evidence do we need for biomarker qualification?
2017
·
Chris Leptak
, Joseph P. Menetski
, et al.
·
Science Translational Medicine
·
83
Regulatory Pathways for Qualification and Acceptance of Digital Health Technology‐Derived Clinical Trial Endpoints: Considerations for Sponsors
2024
·
Jessie P. Bakker
, Elena S. Izmailova
, et al.
·
Clinical Pharmacology & Therapeutics
·
34
PDF
Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design
2020
·
Maria T. Abreu
, William J. Sandborn
, et al.
·
Gastroenterology
·
31
Remote Digital Monitoring for Medical Product Development
2020
·
Elena S. Izmailova
, John A. Wagner
, et al.
·
Clinical and Translational Science
·
25
PDF
Next-Generation Medicines: Past Regulatory Experience and Considerations for the Future
2014
·
M A Pacanowski
, C Leptak
, et al.
·
Clinical Pharmacology & Therapeutics
·
25
Considerations for Developing Targeted Therapies in Low‐Frequency Molecular Subsets of a Disease
2018
·
Robert N. Schuck
, Janet Woodcock
, et al.
·
Clinical Pharmacology & Therapeutics
·
24
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers
2021
·
James L. Januzzi
, John M. Canty
, et al.
·
Journal of the American College of Cardiology
·
15
PDF
The FNIH Biomarkers Consortium embraces the BEST
2019
·
Joseph P. Menetski
, Christopher P. Austin
, et al.
·
Nature Reviews Drug Discovery
·
12
Biomarkers in drug development
2021
·
Robert N. Schuck
, Jana G. Delfino
, et al.
·
Elsevier eBooks
·
7
Exploring the Landscape of Biomarkers in Spinal Cord Injury
2025
·
Paulina S. Scheuren
, Bethany R. Kondiles
, et al.
·
Topics in Spinal Cord Injury Rehabilitation
·
6
PDF
Establishing a Public Resource for Acceptable Surrogate Endpoints to Support FDA Marketing Applications
2022
·
Abena S. Agyeman
, Jeffrey N. Siegel
, et al.
·
Frontiers in Medicine
·
6
PDF
Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022
2024
·
Rashmi Sinha
, Fabrizio De Benedetti
, et al.
·
Pediatric Rheumatology
·
1
PDF
Show more works
View as search
Works count:
15
Citation count:
506
H-index:
10
I10-index:
10
Year
Topic
Type